3-(Dimethoxymethylsilyl)propylamine

We are 3-(Dimethoxymethylsilyl)propylamine CAS:3663-44-3 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests


Chemical Name:3-(Dimethoxymethylsilyl)propylamine
CAS.NO:3663-44-3
Synonyms:3-Aminopropyldimethoxymethylsilane; methyldimethoxy-3-aminopropylsilane; 3-aminopropylmethyldimethoxysilane;
3-Methyldimethoxysilylpropylamine;
Molecular Formula:C6H17NO2Si
Molecular Weight:163.29000
 
Physical and Chemical Properties:
Density:0.908;
Boiling point:203.3^oC;
Flash point:76.8^oC;
Index of Refraction:1.421;
 
Specification:
Appearance:Colorless transparent liquid
Purity(GC):≥97.0%
 
Packing:210 L/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:3-Aminopropylmethyldiethoxysilane, Silane coupling agent SCA-A10T, is an important additive in many applications. For example it can be used as an additive in cold-curing phenolic and furan foundry resins to improve the flexural strength of sand/resin elements with very long shelf life of the resins. Further examples are: – Glass and metal primers – abrasives: As additive to phenolic resin binders – mineral-filled composites: For pretreatment of fillers and pigments or as additive – synthesis of functional silicones(amino-silicone oil for textile auxiliary)




Related News: The upstream industry for the R & D, production and sales of pharmaceutical intermediates is the basic chemical raw material industry, and the downstream industry is the chemical bulk drug and chemical pharmaceutical preparation industry.3-Dimethylaminopropylchloride hydrochloride GlaxoSmithKline (GSK) is at the bottom of the top 20 list with the lowest percentage R&D spend/annual revenue at 12%.”4'-aminobenzanilida CAS:17625-83-1 GlaxoSmithKline (GSK) is at the bottom of the top 20 list with the lowest percentage R&D spend/annual revenue at 12%.”Methyl [(dimethoxyphosphoryl)sulfanyl]acetate CAS:57212-78-9 GlaxoSmithKline (GSK) is at the bottom of the top 20 list with the lowest percentage R&D spend/annual revenue at 12%.”If an API is not ultrapure, a medicine cannot meet the strict quality criteria so the quality of an API plays a very important role.